Institut Claudius Regaud
Clinical trials sponsored by Institut Claudius Regaud, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New shorter radiation course aims to ease sarcoma treatment for seniors Results expected Sep 2026 (estimated)
- New blood test could spot cancer cells better in advanced breast and prostate cancer Results expected Nov 2026 (estimated)
- Scientists hunt for biomarkers of PARP inhibitor resistance in BRCA breast cancer Results expected Jan 2027 (estimated)
- Cervical smear DNA may reveal ovarian cancer years before symptoms Results expected Jan 2027 (estimated)
- Hypnosis may calm cancer patients during radiation Results expected Aug 2027 (estimated)
-
New radiation technique tested for aggressive brain cancer
Disease control Stopped earlyThis phase 3 trial tested two types of radiation therapy for glioblastoma, a fast-growing brain tumor. One group received standard 3D radiation, while the other got a more precise intensity-modulated radiation guided by MRI scans. Both groups also took the chemotherapy drug temoz…
Phase 3 • Sponsor: Institut Claudius Regaud • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Pazopanib dose hunt in frail seniors halted early
Disease control Stopped earlyThis phase 1 study tested the cancer drug pazopanib in 18 frail elderly patients (aged 75+) with metastatic cancers like kidney, lung, or breast cancer. The goal was to find the highest safe dose by starting at 400 mg daily and increasing if tolerated. The study was terminated ea…
Phase 1 • Sponsor: Institut Claudius Regaud • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Breath-Tracking sensor aims to sharpen lung cancer scans
Diagnosis Stopped earlyResearchers are testing a breathing sensor called SPI that synchronizes PET/CT scans with a patient's breath. The goal is to see if this device can produce clearer images of lung tumors and nodules. Each participant undergoes a scan with both the SPI device and a standard breathi…
Sponsor: Institut Claudius Regaud • Aim: Diagnosis
Last updated Sep 20, 2026 00:00 UTC